CAS 123205-52-7

Trelnarizine

Description:

Trelnarizine is a chemical compound primarily recognized for its use as an anti-psychotic and anti-anxiety medication. It belongs to the class of drugs known as calcium channel blockers, which modulate the influx of calcium ions in cells, thereby influencing neurotransmitter release and neuronal excitability. Trelnarizine exhibits properties that can help in the management of various neurological disorders, including anxiety and certain types of movement disorders. The compound is characterized by its ability to cross the blood-brain barrier, making it effective in central nervous system applications. Its pharmacological profile includes sedative effects, which can be beneficial in treating conditions associated with heightened anxiety or agitation. Additionally, Trelnarizine has been studied for its potential neuroprotective effects, suggesting a role in mitigating neurodegenerative processes. As with many pharmaceuticals, the efficacy and safety profile of Trelnarizine is subject to ongoing research, and its use should be guided by clinical evidence and regulatory approvals.

Formula: C₂₈H₃₀F₂N₂O₂

InChI: InChI=1/C28H30F2N2O2/c1-33-26-14-5-21(20-27(26)34-2)4-3-15-31-16-18-32(19-17-31)28(22-6-10-24(29)11-7-22)23-8-12-25(30)13-9-23/h3-14,20,28H,15-19H2,1-2H3/b4-3+

Synonyms:

• Trelnarizine [INN]
• (E)-1-(Bis(p-fluorophenyl)methyl)-4-(3,4-dimethoxycinnamyl)piperazine
• Unii-Se8X571K4C
• 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl]piperazine